Aromatase and endometriosis.

Area of Science:

• Endocrinology
• Reproductive Medicine
• Oncology

Background:

• Estrogen is crucial for endometriosis development and growth.
• Normal endometrium lacks detectable aromatase enzyme activity, preventing local estrogen production.
• Endometriotic tissue exhibits high aromatase enzyme levels, leading to significant local estrogen synthesis.

Purpose of the Study:

• To investigate the role of aromatase p450 in endometriosis.
• To explore the positive feedback loop between estrogen and prostaglandin E(2) in endometriosis.
• To evaluate the efficacy of aromatase inhibitors in managing endometriosis-associated pain.

Main Methods:

• Assessing aromatase enzyme activity in normal and endometriosis tissues.
• Investigating the induction of aromatase by prostaglandin E(2).
• Examining the effect of estrogen on cyclo-oxygenase-2 and prostaglandin E(2) formation.
• Conducting pilot trials with aromatase inhibitors.

Main Results:

• Endometriosis tissue shows significantly higher aromatase enzyme activity than normal endometrium.
• Prostaglandin E(2) stimulates aromatase activity and local estrogen production in endometriosis.
• Estrogen upregulates cyclo-oxygenase-2, increasing prostaglandin E(2) formation, creating a positive feedback loop.
• Pilot trials indicated that aromatase inhibitors can alleviate pelvic pain in endometriosis patients.

Conclusions:

• Aromatase inhibitors can effectively target the estrogen-prostaglandin feedback loop in endometriosis.
• Inhibition of local estrogen production via aromatase inhibitors presents a promising therapeutic strategy for endometriosis.
• Targeting aromatase offers a novel approach to reduce pain and potentially slow the progression of endometriosis.